Lymphosarcoma cell leukemia.A clinicopathologic study
نویسندگان
چکیده
منابع مشابه
A clinicopathologic study of precancerous skin lesions
Background: Precancerous lesions are disorders that are highlylikely to become malignant. Early diagnosis of precancerous skinlesions helps to prevent skin cancers. The aim of this study wasclinicopathological assessment of precancerous skin lesions inpatients referred to the dermatology department of Imam Rezahospital.Method: Two hundred and nine patients who were diagnosed withprecancerous le...
متن کاملLymphosarcoma cell leukemia: the contribution of cell surface study to diagnosis.
Cell surface immunoglobulin, complement receptor, and spontaneous rosette formation with sheep erythrocytes were investigated in 43 patients with malignant lymphoma, including 13 with lymphosarcoma cell leukemia, and in 59 patients with chronic lymphocytic leukemia. The quantity of immunoglobulin on the lymphocyte surface was estimated from the intensity of fluorescent staining with fluorescein...
متن کاملMantle cell lymphoma: a clinicopathologic study of 80 cases.
Mantle cell lymphoma (MCL) is a relatively uncommon yet distinct type of malignant lymphoma whose clinical and pathological characterization has been limited by the small numbers of cases published to date. We studied 80 cases of MCL seen at a single institution over 7 years to determine both clinical and pathological prognostic factors. The patients in this study were predominantly male (70%) ...
متن کاملUveal lymphosarcoma.
LYMPHOMATOUS tumours involving the lids and orbit have been recognized and repeatedly reported in the literature for many years; intra-ocular involvement on the contrary is rare if the lymphomatous infiltrations associated with lymphatic leukaemia are excluded. Kukain (1935) and Triebenstein (1920) have each described a case of uveal lymphosarcoma complicated by secondary glaucoma, and other is...
متن کاملClinicopathologic Study in Uterine Cancer
Patients with primary advanced or recurrent endometrial cancer are relatively uncommon and deserve better treatment options. Current treatment options are surgery, radiotherapy, and systemic therapy. Since the outcome is still poor, there is a need to improve our knowledge on molecular markers in order to personalize treatment. In addition, we need to continue the search for new treatment strat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1970
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(197011)26:5<1082::aid-cncr2820260517>3.0.co;2-l